A global network of non-profit organisations supporting those affected by Niemann-Pick diseases.

Our website is under renovation, stay tuned for updates!

Cyclo Therapeutics Announces Submission of New Drug Application to FDA for Trappsol® Cyclo™ (remibetadex) for the Treatment of Niemann-Pick Disease Type C

October 29, 2026 Dear NPC Organizational Leaders, As we approach the conclusion of Niemann-Pick Disease Awareness Month, we are...

Cyclo Therapeutics Provides Update on Trappsol® Cyclo™ Development Programme

ASMD Project – The Invisible Years – Survey

Proposed Patient Organisation Recruitment Communication At Niemann-Pick UK, we know that the road to an ASMD diagnosis is often...